PROLANZA ODT olanzapine 20mg orally disintegrating tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

olanzapine, Quantity: 20 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Olanzapine

Pharmaceutical form:

Tablet, orally disintegrating

Composition:

Excipient Ingredients: magnesium stearate; hyprolose; colloidal anhydrous silica; purified talc; lactose monohydrate; crospovidone; Flavour

Administration route:

Oral

Units in package:

20, 21, 14, 28, 50, 10, 40, 7, 60, 30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Product summary:

Visual Identification: Yellow, round flat tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2011-08-12